Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT05687058
Status:
RECRUITING
Last Update Posted:
2025-06-25
First Post:
2022-09-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Empagliflozin in ESKD - A Feasibility Study
Sponsor:
University of Mississippi Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-16
First Submit QC Date:
None
Study First Post Date:
2023-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-19
Last Update Post Date:
2025-06-25
Last Update Post Date Type:
ACTUAL